SP
AUTL

SmartHarvest Portfolios’s Autolus Therapeutics AUTL Stock Holding History

SmartHarvest Portfolios’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
63,602
+4,417
+7% +$6.93K 0.03% 403
2026
Q1 		$81.7K Buy
59,185
+37,820
+177% +$57.4K 0.03% 339
2025
Q4 		$42.5K Buy
+21,365
New +$32.8K 0.01% 340

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SmartHarvest Portfolios's AUTL Position: Q2 2026 in Review

SmartHarvest Portfolios increased its Autolus Therapeutics (AUTL) stake by 7.5% in Q2 2026, buying an estimated $6.93K and bringing the position to 63,602 shares worth $102K. The position accounts for 0.03% of the portfolio, ranked #403.

SmartHarvest Portfolios first reported a position in AUTL in Q4 2025 and has held it in 3 quarters since. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • SmartHarvest Portfolios held 63,602 shares of Autolus Therapeutics worth $102K as of Q2 2026.
  • SmartHarvest Portfolios bought 4,417 Autolus Therapeutics shares in Q2 2026, an estimated $6.93K.
  • Autolus Therapeutics made up 0.03% of SmartHarvest Portfolios's portfolio in Q2 2026, its #403 holding.
  • SmartHarvest Portfolios first reported a position in Autolus Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on SmartHarvest Portfolios's 13F filing for Q2 2026, filed 4 Aug 2026.